IRWD

Ironwood Pharmaceuticals, Inc.

10.58 USD
+0.28 (+2.72%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Ironwood Pharmaceuticals, Inc. stock is up 11.37% since 30 days ago. The next earnings date is Feb 15, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 13 December’s closed higher than November. In the last 4 Unusual Options Trades, there were 3 CALLs, 1 PUT.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
10 Oct 16:10 19 Apr, 2024 7.50 CALL 90 2
10 Oct 16:11 19 Apr, 2024 7.50 PUT 500 285
31 Oct 19:28 19 Apr, 2024 10.00 CALL 203 496
01 Nov 19:19 15 Dec, 2023 10.00 CALL 675 2589

About Ironwood Pharmaceuticals, Inc.

Ironwood Pharmaceuticals, Inc. focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation.